Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-24 @ 11:07 PM
NCT ID:
NCT02303769
Eligibility Criteria:
Inclusion Criteria:
* Over 50 years old, BPH diagnosted, Adult Male Subject
* IPSS ≥ 13 point
* PSA \< 4ng/mL
* 5ml/sec \< Qmax ≤ 15ml/sec
Exclusion Criteria:
* Prostatic cancer
* 250ml \< PVR
* ALT or AST \> 2 times (Upper Normal Range)
* Total Bilirubin \> 1.5 times (Upper Normal Range)
* Treated with α-adrenalin receptor blocker within 2weeks before screening
* Treated with 5Alpha-Reductase Inhibitor within 6 months before screening
* Treated with phytotherapy within 2weeks before screening
* Treated with Anabolic Steroid within 6 months before screening
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
50 Years
Study:
NCT02303769
Study Brief:
Protocol Section:
NCT02303769